Mersana Therapeutics Inc (MRSN) Stock Price, Quote & News

Company Profile

Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs. The company develops Emi-Le (XMT-1660), a B7-H4-targeting Dolasynthen ADC candidate, which is in Phase 1 clinical trial; and XMT-2056, an Immunosynthen ADC targeting a novel human epidermal growth factor receptor 2 that is in Phase 1 clinical trial. Its preclinical products portfolio includes XMT-2068 and XMT-2175. It has strategic research and dev...

Industry: Biotechnology

Sector: Healthcare

Phone: (617) 498-0020

Website: www.mersana.com

Address:

840 Memorial Drive, Cambridge, United States

Konnielinguus Jun. 16 at 1:05 PM

$MRSN indeed that's a good sign

1 · Reply

studmuffin69 Jun. 16 at 12:44 PM

$MRSN Bunch of "Form 4" and a 8-k getting more interesting

0 · Reply

BoloTheGrey Jun. 14 at 12:23 PM

$MRSN What do you think? https://www.tipranks.com/news/company-announcements/mersana-therapeutics-approves-key-proposals-at-annual-meeting

0 · Reply

KING00777 Jun. 14 at 2:45 AM

$MRSN Where is the 4am id..t? J...r?? All time throwing up targets. Useless fellow.

0 · Reply

KING00777 Jun. 14 at 12:58 AM

$MRSN Don't be worried. This is a range bound stock. Better to buy near 0.335 and exit 0.43. This is not closing or going to the sky.

0 · Reply

pauliegone Jun. 14 at 12:54 AM

$MRSN So your out then?

0 · Reply

GoofyAhh Jun. 14 at 12:29 AM

$MRSN There is not much left in this stock R/S will knock it down into the $0.1 territory. Most likely it will be 9:1 as they have done before. They are betting everything on Emi-Le, and most likely its a dud. Grasping at straws at this point...

0 · Reply

BEATWALLSTREET Jun. 13 at 11:10 PM

$MRSN What was the outcome of yesterday’s reverse split meeting? Did they announce the split ratio and the effective date?

1 · Reply

KING00777 Jun. 13 at 2:02 PM

$MRSN I don't see paid actors on this forum now. Heading to my final taerget of 0.337 and if it reverses then good . Else 0.26 target intact.

0 · Reply

Rony4AM Jun. 13 at 11:22 AM

$MRSN -

0 · Reply

Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting

May 20, 2025, 8:00 AM EDT - 27 days ago

Mersana Therapeutics to Present at Upcoming Investor Conferences

May 15, 2025, 10:06 AM EDT - 4 weeks ago

Mersana Therapeutics, Inc. (MRSN) Q1 2025 Earnings Call Transcript

May 15, 2025, 9:20 AM EDT - 4 weeks ago

CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results

May 15, 2025, 7:00 AM EDT - 4 weeks ago

Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results

May 6, 2025, 7:00 AM EDT - 5 weeks ago

Mersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast Cancer

Apr 23, 2025, 10:12 AM EDT - 7 weeks ago

Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting

Apr 4, 2025, 4:05 PM EDT - 2 months ago

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 1, 2025, 8:01 AM EDT - 2 months ago

Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress

Mar 3, 2025, 10:13 AM EST - 3 months ago

Mersana Therapeutics, Inc. (MRSN) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 7:01 AM EST - 3 months ago

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 24, 2025, 4:01 PM EST - 4 months ago

Mersana Therapeutics to Host Fourth Quarter and Year End 2024 Conference Call on March 3, 2025

Jan 30, 2025, 8:00 AM EST - 4 months ago

Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference

Jan 10, 2025, 12:49 PM EST - 5 months ago

Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?

Jan 10, 2025, 6:02 AM EST - 5 months ago

Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)

Jan 10, 2025, 6:00 AM EST - 5 months ago

Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer

Dec 19, 2024, 7:17 AM EST - 6 months ago

Mersana Therapeutics: We're About To Find Out If ADC Platform Is More Tolerable

Nov 13, 2024, 1:26 PM EST - 7 months ago

Mersana Therapeutics, Inc. (MRSN) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 7:00 AM EST - 7 months ago

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results

Nov 6, 2024, 8:00 AM EST - 7 months ago

Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024

Aug 13, 2024, 12:55 PM EDT - 10 months ago

Mersana Therapeutics, Inc. (MRSN) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 7:00 AM EDT - 10 months ago

Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results

Aug 6, 2024, 8:00 AM EDT - 11 months ago

Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024

May 9, 2024, 2:09 PM EDT - 1 year ago

Mersana Therapeutics, Inc. (MRSN) Q1 2024 Earnings Call Transcript

May 9, 2024, 6:59 AM EDT - 1 year ago

Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

May 3, 2024, 4:30 PM EDT - 1 year ago

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 2, 2024, 8:00 AM EDT - 1 year ago

Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024

Feb 28, 2024, 2:10 PM EST - 1 year ago

Mersana Therapeutics, Inc. (MRSN) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 7:00 AM EST - 1 year ago

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

Feb 21, 2024, 8:00 AM EST - 1 year ago

Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024

Feb 1, 2024, 8:00 AM EST - 1 year ago

Mersana Therapeutics to Participate in Guggenheim's 6th Annual Biotechnology Conference

Jan 5, 2024, 8:01 AM EST - 1 year ago

Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 7, 2023, 1:34 PM EST - 1 year ago

Mersana Therapeutics, Inc. (MRSN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 7:00 AM EST - 1 year ago

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

Oct 31, 2023, 4:30 PM EDT - 1 year ago

Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023

Oct 31, 2023, 8:00 AM EDT - 1 year ago

Mersana Therapeutics Announces FDA has Lifted Clinical Hold on Phase 1 Clinical Trial of XMT-2056

Sep 6, 2023, 7:00 AM EDT - 1 year ago

Mersana Therapeutics Announces Changes in Leadership

Aug 8, 2023, 8:00 AM EDT - 2 years ago

Mersana Therapeutics Announces Second Quarter 2023 Financial Results

Jul 27, 2023, 7:06 AM EDT - 2 years ago

Mersana Therapeutics Announces Topline Data from UPLIFT Clinical Trial in Patients with Platinum-Resistant Ovarian Cancer and Strategic Reprioritization

Jun 27, 2023, 5:45 AM EDT - 2 years ago

MRSN NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Mersana Therapeutics, Inc.

Jun 15, 2023, 8:03 AM EDT - 2 years ago

US FDA puts Mersana Therapeutics' ovarian cancer drug studies on partial hold

Jun 15, 2023, 8:00 AM EDT - 2 years ago

Mersana Therapeutics stock craters after FDA halts trials of ovarian cancer treatment after bleeding events

Jun 15, 2023, 7:30 AM EDT - 2 years ago

Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials

May 9, 2023, 1:45 PM EDT - 2 years ago

Mersana Therapeutics, Inc. (MRSN) Q1 2023 Earnings Call Transcript

May 9, 2023, 7:00 AM EDT - 2 years ago

Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results

Konnielinguus Jun. 16 at 1:05 PM

$MRSN indeed that's a good sign

1 · Reply

studmuffin69 Jun. 16 at 12:44 PM

$MRSN Bunch of "Form 4" and a 8-k getting more interesting

0 · Reply

BoloTheGrey Jun. 14 at 12:23 PM

$MRSN What do you think? https://www.tipranks.com/news/company-announcements/mersana-therapeutics-approves-key-proposals-at-annual-meeting

0 · Reply

KING00777 Jun. 14 at 2:45 AM

$MRSN Where is the 4am id..t? J...r?? All time throwing up targets. Useless fellow.

0 · Reply

KING00777 Jun. 14 at 12:58 AM

$MRSN Don't be worried. This is a range bound stock. Better to buy near 0.335 and exit 0.43. This is not closing or going to the sky.

0 · Reply

pauliegone Jun. 14 at 12:54 AM

$MRSN So your out then?

0 · Reply

GoofyAhh Jun. 14 at 12:29 AM

0 · Reply

BEATWALLSTREET Jun. 13 at 11:10 PM

$MRSN What was the outcome of yesterday’s reverse split meeting? Did they announce the split ratio and the effective date?

1 · Reply

KING00777 Jun. 13 at 2:02 PM

$MRSN I don't see paid actors on this forum now. Heading to my final taerget of 0.337 and if it reverses then good . Else 0.26 target intact.

0 · Reply

Rony4AM Jun. 13 at 11:22 AM

$MRSN -

0 · Reply

Rony4AM Jun. 13 at 11:01 AM

$MRSN -

0 · Reply

Rony4AM Jun. 13 at 10:16 AM

$MRSN -

1 · Reply

KING00777 Jun. 12 at 2:09 PM

$MRSN Perfect predictions..

0 · Reply

KING00777 Jun. 12 at 1:49 PM

$MRSN Total Gone case.. as told. Heading to 0.36 and then 0.338

0 · Reply

Rony4AM Jun. 12 at 10:12 AM

$MRSN - Finally re-blocked by KING00777 kingTA.. Again !! Does this character ever stop.. ( I have to say that the feed look way better and less buggy now ) So sending my regards and thanks anyways.

1 · Reply

EsotericDark Jun. 12 at 9:35 AM

$CLDI Right now it's this, $MRSN and $BDSX. Comfortably in the green on all three right now. Feeling quite good. We'll see how this progresses. Previously held $LYRA from February up until its massive run-up at the start of the month. Profits have been split up between these three positions.

0 · Reply

Rony4AM Jun. 12 at 8:41 AM

$MRSN

0 · Reply

Rony4AM Jun. 11 at 9:16 PM

$MRSN

0 · Reply

KING00777 Jun. 11 at 9:14 PM

$MRSN After the split news tomorrow, it will trade around 0.3380. Good luck to longs.

0 · Reply

Rony4AM Jun. 11 at 8:59 PM

$MRSN